Open call with SSH aspects in European Partnership for Personalised Medicine

Deadline

Deadline for pre-proposal submission: 18 February 2025 (14:00 CET)

Deadline for full- proposal submission: 17 June 2025 (14:00, CEST)

Short Call Abstract

The overall objectives of the call will be to: 

• Support research projects in human health on pharmacogenomic strategies for personalised medicine approaches that address one or more of the following aspects:
  • identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination.
  • validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes.
  • use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi -medication).
     
• Encourage and enable interdisciplinary collaborations, i.e. multi-actor research by engaging a range of other relevant disciplines such as pre-clinical and clinical research, bioinformatics/health informatics/data research, ELSA research, implementation research or health economics research connected to the proposed research topic, including end-user perspective analysis to support the implementation of the research outcomes into clinical practice.

• Encourage cross-sectorial collaborations, by including the private sector (e.g. SMEs, small and medium-sized enterprises), industry, as well as regulatory/HTA agencies and patient organisations.

• Establish participatory research, i.e. active representation of patients or citizens as part of research projects

SSH aspects

Economics, Law, Ethics, Sociology  

Countries

Austria*, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany*, Greece*, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal*, Spain, Sweden* and Turkiye* (contact list is provided below). 

Besides national funders, the following regions are participating:  Flanders (Belgium), Wallonia Brussels Federation (Belgium), Saxony (Germany)*, Lombardy (Italy), Tuscany (Italy), Azores (Portugal), Centro Region (Portugal)*, Andalusia (Spain), Catalonia (Spain) and Navarre (Spain).

*decision on participation is still pending

The information provided in this pre-announcement is indicative and may be subject to changes. The final call information is expected to be published on the EP PerMed website in December 2024.